{"id":772602,"date":"2023-07-26T10:40:38","date_gmt":"2023-07-26T14:40:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/"},"modified":"2023-07-26T10:40:38","modified_gmt":"2023-07-26T14:40:38","slug":"rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/","title":{"rendered":"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWARK, Calif., July  26, 2023  (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company\u2019s business and financial results.<\/p>\n<p>\n        <strong>Conference Call and Webcast Details: <\/strong><br \/>\n        <br \/>Date: August 10, 2023<br \/>Time: 2:00 pm PT (5:00 pm ET)<br \/>Dial In Numbers: 1 (888) 886-7786 (U.S. Toll Free) \/ 1 (416) 764-8658 (International)<br \/>Conference ID: 29873479<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5csGzFhBRZE75UfJS-IU0A2SHUE_FJ-cIxIhLoCv0te0y0dtcc6-L1pFUcznxF5C926dzusjktLbpiBVGnxLk-e25U3_gwKJxZe0tGvjpdB7lmHskw6B2BVsDpjDXSpP3i7G29kE3vTvd8Apr7zQaeJ0C6QEBB2gDUm8WlatsBRs7QBsmGyWi_CeLzfVLe1vSZFIIzUYOTqwln67hjF9d87W09X-4PYUcQ0TK8i_ikw=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1624922&amp;tp_key=7933f8175f<\/a><\/p>\n<p>A replay of the call will be available by visiting the &#8220;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U8ThmXFepSFtVUD0lt2iGovnYj84BRkncRDzl-G3qHOWMENRHyuOlTSBY04qA_7MTNxzG6TQ_7q_UiP-7NizpA==\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a>&#8221; section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days.<\/p>\n<p>\n        <strong>About Rain Oncology Inc.<\/strong><br \/>\n        <br \/>Rain Oncology Inc. is a precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. Rain\u2019s lead product candidate, milademetan, is a small molecule, oral inhibitor of MDM2-p53 complex that reactivates p53.<\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Mahima Agochiya<br \/>Rain Oncology<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BQqU2blHIX8nQnyfzSzqQ2j57_F2sH-TLOyu80J73803BNVDakySgCt7nc-TXE-yJFykWneWnItwNiXzcU8GRDrSFlnVDXM7s_t8J-AOPhRuMpPcn7UuLxEmPlEdgy5a\" rel=\"nofollow noopener\" target=\"_blank\">magochiya@rainoncology.com<\/a><\/u>\u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Dan Ferry<br \/>LifeSci Advisors<br \/>+1.617.430.7576<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3JiM75U7AfnjbvVQLGG73zJvKG7BIHs-6bv0RMeua2wZdoN4FSZhWI-sB2_4oHVNQ1eixnHKwes7MT2sfm4QTImjGhYcElkfkXk2qMlQj5QH2JXdxA5vd9xgxHECkixF\" rel=\"nofollow noopener\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/M2I4ZGM4YTMtZjBjMC00YzgyLTkwZTUtYjliMDFjMDk5ZDdlLTEyMTc3NTI=\/tiny\/Rain-Therapeutics-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company\u2019s business and financial results. Conference Call and Webcast Details: Date: August 10, 2023Time: 2:00 pm PT (5:00 pm ET)Dial In Numbers: 1 (888) 886-7786 (U.S. Toll Free) \/ 1 (416) 764-8658 (International)Conference ID: 29873479Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1624922&amp;tp_key=7933f8175f A replay of the call will be available by visiting the &#8220;Events&#8221; section of the Rain website after the conclusion of the presentation &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772602","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company\u2019s business and financial results. Conference Call and Webcast Details: Date: August 10, 2023Time: 2:00 pm PT (5:00 pm ET)Dial In Numbers: 1 (888) 886-7786 (U.S. Toll Free) \/ 1 (416) 764-8658 (International)Conference ID: 29873479Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1624922&amp;tp_key=7933f8175f A replay of the call will be available by visiting the &#8220;Events&#8221; section of the Rain website after the conclusion of the presentation &hellip; Continue reading &quot;Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-26T14:40:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023\",\"datePublished\":\"2023-07-26T14:40:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/\"},\"wordCount\":212,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/\",\"name\":\"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=\",\"datePublished\":\"2023-07-26T14:40:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/","og_locale":"en_US","og_type":"article","og_title":"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023 - Market Newsdesk","og_description":"NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company\u2019s business and financial results. Conference Call and Webcast Details: Date: August 10, 2023Time: 2:00 pm PT (5:00 pm ET)Dial In Numbers: 1 (888) 886-7786 (U.S. Toll Free) \/ 1 (416) 764-8658 (International)Conference ID: 29873479Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1624922&amp;tp_key=7933f8175f A replay of the call will be available by visiting the &#8220;Events&#8221; section of the Rain website after the conclusion of the presentation &hellip; Continue reading \"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-26T14:40:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023","datePublished":"2023-07-26T14:40:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/"},"wordCount":212,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/","name":"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=","datePublished":"2023-07-26T14:40:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDcyNiM1NzA5MjE0IzIyMDYxOTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-report-second-quarter-2023-financial-results-and-provide-a-corporate-update-on-august-10-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772602"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772602\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}